🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great opportunity for anyone interested in pursuing a PhD at Stanford in cancer biology 👇

Interested in solid tumor cell therapy and #TIL therapy? Have a PhD in computational biology/bioinformatics? The Betof Lab (co-mentor Dr. Zina Good Zinaida Good) is hiring a computational postdoc focused on TIL therapy! Stanford Cancer Institute Apply here: postdocs.stanford.edu/prospective/op…

Great work by my dear friend and outstanding investigator Mohammad Rashidian and team Dana-Farber Congratulations!

SCI leader Quynh-Thu Le & others found that a binary supracluster (BSCgal) combining gold nanoclusters with siRNA targeting galectin-1 enhances anti-tumor immunity in stereotactic ablative radiotherapy (#SABR). go.nature.com/3NHF7YO Quynh Thu Le

It’s not easy to do large randomized neoadjuvant trials in rare diseases, and practice changing at that.Congrats David Kirsch, MD, PhD and Yvonne Mowery and team!

If you're interested in hearing about our past and current work, check out this upcoming MRS webinar

Proud to share early work from my 1st year in the Garcia Lab! 🧬 the tldr: in just a few months, we go from computational design —> real cancer-specific T cell engagers! biorxiv.org/content/10.110…

Another landmark day for solid tumor cell therapy at Stanford Cancer Institute with our first infusion of FDA approved afami-cel (Tecelra), an engineered TCR T cell therapy for synovial #sarcoma. We are thrilled to make this available to our patients!!

fantastic work tracking clonal evolution in response to radiation in sarcoma Everett Moding, MD, PhD Erik Blomain

Did you know - the medicine that President Trump takes each day to lower his risk of having a heart attack is a direct result of NIH funding? Let me explain -

📢 CDMRP to be cut 57%. The vote on this bill could be as early as Tuesday. Melanoma Research Foundation has a link to make it easy to contact your district representative: lnkd.in/g-p-3tRV

Excited to share this work from the Garcia Lab out today in Nature Communications! We engineer "cytokine adaptors", molecular switches that simultaneously block a target cytokine while inducing local activation of alternative cytokine receptors. rdcu.be/ec7GS

ISO TWO #postdocs to work with me on human #macrophage spatial biology. #R01 NIH funded! Stanford University Stanford Pathology using #scRNAseq, #SpatialTranscriptomics, and proteomics. Please RT!

Our study made the cover of Cancer Research! Congrats Faith Ryu (a talented ACRC Stanford Radiation Oncology heading to medical school next year) on this beautiful artwork showing the effect of #radiotherapy on #sarcoma evolution. A 🧵 of key findings from the most recent story from the lab. (1/8)

Congrats again to Faith Ryu on the gorgeous cover, our amazing team in the lab (Erik Blomain, Shaghayegh Soudi - PhD, MSc, @LeakNouth, and many more), and all our collaborators (Anusha Kalbasi, Michael Sargent Binkley, and others not on X)! (8/8)

Our study integrating ctDNA & radiomics to predict outcomes in NSCLC treated with CRT is online at Cancer Discovery! A great collaboration between Steven H. Lin MD Anderson Cancer Center and the labs of Max Diehn, MD/PhD, Ash Alizadeh, MD/PhD 🇺🇸, & Ruijiang Li Stanford Radiation Oncology. 🧵(1/11) doi.org/10.1158/2159-8…

Exciting work from the Daniels lab 🔥 fortunate to have a front row seat

Happy to share the final results of the 🇪🇸 & 🇫🇷 ph2 trial of intratumoral BO-112 + pembro for patients with anti PD-1 resistant #melanoma. 25% ORR and 54% patients alive at 2 years. 16 years of basic and clinical research behind. Some context here 👇🧵 ascopubs.org/doi/10.1200/JC…

BREAKING: We uncovered a potent immune alliance that could change how we treat solid tumors. Published in Cancer Cell , we show that Th17 cells *must* work with B cells to eliminate tumors—and keep it from coming back. 📄 cell.com/cancer-cell/fu… 🧵1/12👇Let’s walk through it: